SCHEMBL13865967

SCHEMBL13865967

CC(C)(C)[Si](C)(C)OCc1cc(OCOCC[Si](C)(C)C)c2nc(-c3cccc4c(=O)n(CCC#N)sc34)c(=O)n(COCC[Si](C)(C)C)c2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13865960 0.90 NPC1 (0.34) —
SCHEMBL13865958 0.87 NPC1 (0.33) —
SCHEMBL13865966 0.87 — —
SCHEMBL13865961 0.86 NPC1 (0.36) —
SCHEMBL13865957 0.84 NPC1 (0.35) —
SCHEMBL13865964 0.84 NPC1 (0.32) —
SCHEMBL13870888 0.81 NPC1 (0.35) —
SCHEMBL14193138 0.79 NPC1 (0.36) —
SCHEMBL14193774 0.78 NPC1 (0.35) —
SCHEMBL13865965 0.78 NPC1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137597-A1 Novel quinoxalinone derivatives MSD K.K. (JP) 2009-05-28 — — US disclosed
US-7388010-B2 Quinoxalinone derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-06-17 — — US disclosed
Send feedback